Actinium Pharmaceuticals, Inc. (ATNM) Operating cash flow 2016–2025
Actinium Pharmaceuticals, Inc. (ATNM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2016: -$20.8M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +25.7% |
| FY2024 | -$33.1M | +30.1% |
| FY2023 | -$47.3M | -647.6% |
| FY2022 | $8.6M | +141.4% |
| FY2021 | -$20.9M | +3.5% |
| FY2020 | -$21.6M | -0.7% |
| FY2019 | -$21.5M | -4.3% |
| FY2018 | -$20.6M | +4.6% |
| FY2017 | -$21.6M | -3.7% |
| FY2016 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATNM financial trends
ATNM RevenueATNM Net incomeATNM Net marginATNM Gross profitATNM Gross marginATNM Operating incomeATNM Operating marginATNM Free cash flowATNM Capital expendituresATNM Return on equityATNM Stock buybacksATNM Dividends paidATNM Total assetsATNM Total liabilitiesATNM Shareholders’ equityATNM overview →